180 related articles for article (PubMed ID: 23991727)
21. Prognostic significance of alpha-methylacyl-coA racemase among men with high grade prostatic intraepithelial neoplasia in prostate biopsies.
Stewart J; Fleshner N; Cole H; Toi A; Sweet J
J Urol; 2008 May; 179(5):1751-5; discussion 1755. PubMed ID: 18343427
[TBL] [Abstract][Full Text] [Related]
22. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.
Wang W; Epstein JI
Am J Surg Pathol; 2008 Jan; 32(1):65-71. PubMed ID: 18162772
[TBL] [Abstract][Full Text] [Related]
23. Application of alpha-methylacyl coenzyme A racemase immunohistochemistry in the diagnosis of prostate cancer: a review.
Adley BP; Yang XJ
Anal Quant Cytol Histol; 2006 Feb; 28(1):1-13. PubMed ID: 16566275
[TBL] [Abstract][Full Text] [Related]
24. Partial atrophy on prostate needle biopsy cores: a morphologic and immunohistochemical study.
Wang W; Sun X; Epstein JI
Am J Surg Pathol; 2008 Jun; 32(6):851-7. PubMed ID: 18408595
[TBL] [Abstract][Full Text] [Related]
25. Basal cell carcinoma of the prostate gland: a case report and brief review of the basal cell proliferations of the prostate gland.
Bohn OL; Rios-Luna NP; Navarro L; Duran-Peña A; Sanchez-Sosa S
Ann Diagn Pathol; 2010 Oct; 14(5):365-8. PubMed ID: 20850702
[TBL] [Abstract][Full Text] [Related]
26. Prostate-specific antigen, high-molecular-weight cytokeratin (clone 34betaE12), and/or p63: an optimal immunohistochemical panel to distinguish poorly differentiated prostate adenocarcinoma from urothelial carcinoma.
Kunju LP; Mehra R; Snyder M; Shah RB
Am J Clin Pathol; 2006 May; 125(5):675-81. PubMed ID: 16707367
[TBL] [Abstract][Full Text] [Related]
27. Pseudohyperplastic prostatic carcinoma in simple prostatectomy.
Arista-Nasr J; Martinez-Benitez B; Fernandez-Amador JA; Bornstein-Quevedo L; Arceo-Olaiz R; Albores-Saavedra J
Ann Diagn Pathol; 2011 Jun; 15(3):170-4. PubMed ID: 21396868
[TBL] [Abstract][Full Text] [Related]
28. Alpha-methylacyl coenzyme A racemase immunoreactivity in partial atrophy of the prostate.
Adley BP; Yang XJ
Am J Clin Pathol; 2006 Dec; 126(6):849-55. PubMed ID: 17074684
[TBL] [Abstract][Full Text] [Related]
29. Role of p63 in differentiating morphologically ambiguous lesions of prostate.
Baig MK; Hassan U; Mansoor S
J Coll Physicians Surg Pak; 2012 Dec; 22(12):773-7. PubMed ID: 23217483
[TBL] [Abstract][Full Text] [Related]
30. [Morphologic diagnosis and clinical significance of prostatic atypical small acinar proliferation suspicious but not diagnostic of cancer].
Shi HY; Wei LX; Zhou ZH; Wen ZL
Zhonghua Bing Li Xue Za Zhi; 2006 Nov; 35(11):660-3. PubMed ID: 17374209
[TBL] [Abstract][Full Text] [Related]
31. Basal cell hyperplasia: an unusual diagnostic dilemma on prostate needle biopsies.
Hosler GA; Epstein JI
Hum Pathol; 2005 May; 36(5):480-5. PubMed ID: 15948114
[TBL] [Abstract][Full Text] [Related]
32. alpha-methylacyl coenzyme A racemase is immunoreactive in extramammary Paget disease.
Mayes DC; Patterson JW; Ramnani DM; Mills SE
Am J Clin Pathol; 2007 Apr; 127(4):567-71. PubMed ID: 17369131
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis of adenocarcinoma in prostate needle biopsy tissue.
Humphrey PA
J Clin Pathol; 2007 Jan; 60(1):35-42. PubMed ID: 17213347
[TBL] [Abstract][Full Text] [Related]
34. Small cell-like change in prostatic intraepithelial neoplasia, intraductal carcinoma, and invasive prostatic carcinoma: a study of 7 cases.
Lee S; Han JS; Chang A; Ross HM; Montironi R; Yorukoglu K; Lane Z; Epstein JI
Hum Pathol; 2013 Mar; 44(3):427-31. PubMed ID: 23026197
[TBL] [Abstract][Full Text] [Related]
35. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
Tavora F; Epstein JI
Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
[TBL] [Abstract][Full Text] [Related]
36. Utility of racemase and other immunomarkers in the detection of adenocarcinoma in prostatic tissue damaged by high intensity focused ultrasound therapy.
Dalfior D; Delahunt B; Brunelli M; Parisi A; Ficarra V; Novara G; Novella G; Gobbo S; Valotto C; Chilosi M; Menestrina F; Martignoni G
Pathology; 2010 Jan; 42(1):1-5. PubMed ID: 20025473
[TBL] [Abstract][Full Text] [Related]
37. 34BetaE12 and Alfa-Methylacyl Coenzyme A Racemase (AMACR) Antibodies Better Than p63 Antibody Distinguish Normal and Neoplastic Glands in Prostatic Tissue With Thermal Artifacts.
Pierconti F; Rossi ED; Martini M; Sacco E; Bassi PF; Larocca LM
Appl Immunohistochem Mol Morphol; 2019 Apr; 27(4):306-310. PubMed ID: 29346181
[TBL] [Abstract][Full Text] [Related]
38. alpha-Methylacyl coenzyme A racemase, Ki-67, and topoisomerase IIalpha in cystoprostatectomies with incidental prostate cancer.
Santinelli A; Mazzucchelli R; Barbisan F; Lopez-Beltran A; Cheng L; Scarpelli M; Montironi R
Am J Clin Pathol; 2007 Oct; 128(4):657-66. PubMed ID: 17875519
[TBL] [Abstract][Full Text] [Related]
39. [Achievements in morphological diagnosis of prostatic cancer: alpha-methylacyl-coenzyme-A-racemase--a new marker of malignant cell transformation].
Pozharisskiĭ KM; Leenman EE; Arzumanov AA
Arkh Patol; 2005; 67(5):15-9. PubMed ID: 16323473
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic utility of a p63/alpha-methyl coenzyme A racemase (p504s) cocktail in ambiguous lesions of the prostate upon needle biopsy.
Molinié V; Hervé JM; Lugagne PM; Lebret T; Botto H
BJU Int; 2006 May; 97(5):1109-15. PubMed ID: 16643500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
